NIH to Fund Unproven ALS Drugs Under Patient-Backed Law

Only patients who can't get into conventional drug trials are eligible for the program. And their progress must be tracked to gather data about the treatment and their underlying disease, amyotrophic lateral sclerosis, or ALS.
Source: Arkansas Business - Health Care - Category: American Health Source Type: news